Merck & Co. Inc. v. Apotex Inc.

Merck & Co. Inc. v. Apotex Inc.

The prothonotary exercised case management discretion under Rule 3 to limit discovery to the categories and subcategories proposed by Merck, permitting answers only to specified categories and questions listed in Appendices A and B while dismissing the remainder of Apotex's motion; this balanced relevance, proportionality and the burdens of discovery in a long‑running, specially managed complex patent litigation.

Citation
2002 FCT 895
Parties
Plaintiff (cross Defendant): MERCK & CO., INC.; Plaintiff (cross Defendant): MERCK FROSST CANADA & CO.; Plaintiff (cross Defendant): SYNGENTA LIMITED; Plaintiff (cross Defendant): ASTRAZENECA UK LIMITED; Plaintiff (cross Defendant): ASTRAZENECA CANADA INC.; Defendant (cross Plaintiff): APOTEX INC.
Court
Federal Court
Jurisdiction
Canada
Judgment Date
21 August 2002
Procedural Posture
Patent Infringement and Validity Proceedings / Interlocutory Discovery Motion (examination for Discovery Dispute)
Outcome
Apotex's motion dismissed except as to specified questions; Court ordered Merck and Merck Frosst to answer designated questions in Appendices A and B and to produce specified documents; costs awarded to Merck & Co., Inc.
Legal Topics
Discovery, Patent Validity, Patent Infringement, Case Management, Patent Act Interpretation
Source Language
English
Intellectual Property Patent Law Civil Procedure Discovery Patent Validity Patent Infringement Case Management Patent Act Interpretation

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Legal principles 5 Authorities cited 7 Party arguments 2 Amounts and remedies 7
Sign in to unlock

Parties

MERCK & CO., INC.

Plaintiff (cross Defendant)

MERCK FROSST CANADA & CO.

Plaintiff (cross Defendant)

SYNGENTA LIMITED

Plaintiff (cross Defendant)

ASTRAZENECA UK LIMITED

Plaintiff (cross Defendant)

ASTRAZENECA CANADA INC.

Plaintiff (cross Defendant)

APOTEX INC.

Defendant (cross Plaintiff)

Procedural Posture

Patent Infringement and Validity Proceedings / Interlocutory Discovery Motion (examination for Discovery Dispute)

Legal Issues

  1. 1 Scope and limits of examination for discovery
  2. 2 Whether questions based on paragraph 19 of Apotex's defence must all be permitted
  3. 3 Relevance of documents and testimony outside the disputed patent

Ratio Decidendi

The prothonotary exercised case management discretion under Rule 3 to limit discovery to the categories and subcategories proposed by Merck, permitting answers only to specified categories and questions listed in Appendices A and B while dismissing the remainder of Apotex's motion; this balanced relevance, proportionality and the burdens of discovery in a long‑running, specially managed complex patent litigation.

Court Disposition

Apotex's motion dismissed except as to specified questions; Court ordered Merck and Merck Frosst to answer designated questions in Appendices A and B and to produce specified documents; costs awarded to Merck & Co., Inc.

Orders

  • Category 1 dealt with by agreement between parties
  • Category 2: Merck to produce complete documents already produced covering specified 25 questions on Merck's page 18 and answer question at page 1937, l. 8-22